Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on for readers like you. LEARN MORE
Trends we're watching in Biopharma
Request Your Free eBook Now:

"Trends we're watching in Biopharma"

Read about the top three stories STAT reporters will be tracking in Biopharma throughout 2018

Biotech and pharma face a changing landscape in 2018, as Scott Gottlieb’s FDA makes its mark and political uncertainty rules. But some perennial issues aren’t going away: Widespread anger at the rising cost of drugs shows no sign of abating and the dearth of women in biotech continues.

For a fresh take, read what three women in venture capital have to say about the year to come. Check on patent maneuvers, repatriating cash, and outcomes-based contracts for a view of business developments beyond drug pricing.

We’re keeping an eye on legislative battles (will pharma face user fees for over-the-counter drugs?) as well as advertising strategies (will precision marketing win the day?). We take a look at the gold rush in brain technologies while genetic medicine, therapies based on the microbiome, and artificial intelligence are also gaining ground.

Offered Free by: STAT
See All Resources from: STAT


Recommended for Professionals Like You: